We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, entered a global innovation partnership with Catalent to develop a delayed-release formulation of HBC’s OmeGo fish oil.